We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESSA
5801
DELISTED
ESSA Bancorp
ESSA
$64K ﹤0.01%
3,915
+3,152
+413% +$50.1K
HBB icon
5802
Hamilton Beach Brands
HBB
$444M
$64K ﹤0.01%
2,931
+2,460
+522% +$62.4K
RRGB icon
5803
PUT
Red Robin
RRGB
$150M
$64K ﹤0.01%
1,600
+1,500
+1,500% +$63.8K
SEE
5804
PUT
DELISTED
Sealed Air
SEE
$64K ﹤0.01%
1,600
-9,900
-86% -$410K
SQM icon
5805
CALL
Sociedad Química y Minera de Chile
SQM
$20.8B
$64K ﹤0.01%
1,400
-2,600
-65% -$120K
UHS icon
5806
CALL
Universal Health Services
UHS
$10.5B
$64K ﹤0.01%
500
-15,900
-97% -$1.95M
VICR icon
5807
PUT
Vicor
VICR
$9.63B
$64K ﹤0.01%
1,400
-2,300
-62% -$126K
VNET
5808
PUT
VNET Group
VNET
$2.13B
$64K ﹤0.01%
6,300
+1,900
+43% +$18.6K
NAGE
5809
Niagen Bioscience
NAGE
$241M
$64K ﹤0.01%
14,981
+257
+2% +$1.1K
ACGN
5810
DELISTED
Aceragen Inc
ACGN
$64K ﹤0.01%
421
+99
+31% +$14.1K
PZN
5811
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$64K ﹤0.01%
6,658
+5,357
+412% +$49.6K
WCG
5812
CALL
DELISTED
Wellcare Health Plans, Inc.
WCG
$64K ﹤0.01%
+200
New +$56.8K
MLNT
5813
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$64K ﹤0.01%
3,302
+2,086
+172% +$52.7K
BOC icon
5814
Boston Omaha
BOC
$429M
$63K ﹤0.01%
2,082
+1,712
+463% +$40.5K
CELC icon
5815
Celcuity
CELC
$4.43B
$63K ﹤0.01%
2,178
+1,753
+412% +$44.2K
PLSE icon
5816
Pulse Biosciences
PLSE
$2.96B
$63K ﹤0.01%
4,439
+3,640
+456% +$51.7K
VLY icon
5817
CALL
Valley National Bancorp
VLY
$8.1B
$63K ﹤0.01%
5,600
-2,200
-28% -$26.5K
XTIA icon
5818
XTI Aerospace
XTIA
$62.7M
0
FSTX
5819
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$63K ﹤0.01%
1,314
+1,087
+479% +$54.4K
LAIX
5820
DELISTED
LAIX Inc. American Depositary Shares, each representing fourteen Class A Ordinary Shares
LAIX
$63K ﹤0.01%
+357
New +$63K
CHMG icon
5821
Chemung Financial Corp
CHMG
$392M
$62K ﹤0.01%
1,469
+1,230
+515% +$55K
FNWB icon
5822
First Northwest Bancorp
FNWB
$105M
$62K ﹤0.01%
3,975
+3,277
+469% +$52.7K
HSDT icon
5823
Solana Company
HSDT
$99.3M
0
IAT icon
5824
iShares US Regional Banks ETF
IAT
$678M
$62K ﹤0.01%
1,272
+500
+65% +$25.6K
IPGP icon
5825
CALL
IPG Photonics
IPGP
$3.61B
$62K ﹤0.01%
400
+100
+33% +$18.6K

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.